As of my knowledge cutoff in October 2023, there are no records indicating that AstraZeneca PLC has been involved in a class action lawsuit related to insurance fraud in China, nor any reports of the company’s China President being detained by Chinese authorities. It’s possible that these events occurred after my last update or that the information may not be accurate. I recommend verifying this information with current and reliable sources before proceeding.
Subscribe
Analysis and Opinions
Biotechnology
Breaking News
Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) …
